Cargando…
Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines
Live-attenuated measles virus (MeV) has been extraordinarily effective in preventing measles infections and their often deadly sequelae, accompanied by remarkable safety and stability since their first licensing in 1963. The advent of recombinant DNA technologies, combined with systems to generate i...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568972/ https://www.ncbi.nlm.nih.gov/pubmed/36243743 http://dx.doi.org/10.1038/s41541-022-00543-4 |